Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis

Journal of Psychopharmacology

Volumn 25, Issue 1, 2011, Pages 97-104

  Lanciego, José L ^a,b   Barroso Chinea, Pedro ^a,b   Rico, Alberto J ^a,b   Conte Perales, Lorena ^a,b   Callén, Lucía ^b   Roda, Elvira ^a,b   Gómez Bautista, Virginia ^a,b   López, Iciar P ^a,b   Lluis, Carmen ^b   Labandeira García, José L ^b,c   Franco, Rafael ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Basal ganglia; brain; endocannabinoids; in situ hybridization; levodopa

Indexed keywords

CANNABINOID 2 RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; GENE EXPRESSION; GENE SEQUENCE; GLOBUS PALLIDUS; HIPPOCAMPUS; MACACA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; BASAL GANGLIA; CEREBRAL CORTEX; GLOBUS PALLIDUS; HIPPOCAMPUS; MACACA FASCICULARIS; MALE; MOLECULAR TARGETED THERAPY; MOVEMENT DISORDERS; NEUROGLIA; NEURONS; RECEPTOR, CANNABINOID, CB2; RNA, MESSENGER;

EID: 77957293518     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110367732     Document Type: Article

References (42)

1. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366-375.
2. Ashton JC, Glass M. (2007) The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr Neuropharmacol 5: 73-80.
3. Ashton JC, Friberg D., Darlington CL, Smith PF (2006) Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study. Neurosci Lett 396: 113-116.
4. Barroso-Chinea P., Rico AJ, Pérez-Manso M., et al. (2008) Glutamatergic pallidothalamic projections and their implications in the pathophysiology of Parkinson's disease. Neurobiol Dis 31: 422-432.
5. Beltramo M., Bernardini N., Bertorelli R., et al. (2006) CB2 receptor-mediated antihyperalgesia: Possible direct involvement of neural mechanisms. Eur J Neurosci 23: 1530-1538.
6. Benito C., Núñez E., Tolón RM, et al. (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci 23: 11136-11141.
7. Brusco A., Tagliaferro PA, Saez T., Onaivi ES (2008 a) Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. Ann NY Acad Sci 1139: 450-457.
8. Brusco A., Tagliaferro P., Saez T., Onaivi ES (2008 b) Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 62: 944-949.
9. Crossman AR (1987) Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders. Neuroscience 21: 1-40.
10. DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13: 266-271.
11. Fernández-Ruiz J., Pazos MR, García-Arencibia M., Sagredo O., Ramos JA (2008) Role of CB2 receptors in neuroprotective effects of cannabinoids. Molec Cell Endocrinol 286S: S91 - S96.
12. Ferrer B., Asbrock N., Kathuria S., Piomelli D., Guiffrida A. (2003) Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci 18: 1607-1614.
13. Freund TF, Katona I., Piomelli D. (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83: 1017-1066.
14. García-Arencibia M., González S., de Lago E., Ramos JA, Mechoulam R., Fernández-Ruiz J. (2007) Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Res 1134: 162-170.
15. Geisler S., Derst C., Veh RW, Zahm DS (2007) Glutamatergic afferents to the ventral tegmental area in the rat. J Neurosci 27: 5730-5743.
16. Gifford AN, Samiian L., Gatley SJ, Ashby CR (1997) Examination of the effect of the cannabinoid receptor agonists, CP55, 940, on electrically evoked transmitter release from rat brain slices. Eur J Pharmacol 324: 187-192.
17. Golech SA, McCarron RM, Chen Y., et al. (2004) Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Mol Brain Res 132: 87-92.
18. Gong J. -P, Onaivi ES, Ishiguro H., et al. (2006) Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Res 1071: 10-23. (Pubitemid 43255471)
19. Howlett AC, Barth F., Bonner TI, et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161-202.
20. Hur EE, Zaborszky L. (2005) Vglut2 afferents to the medial prefrontal and primary somatosensory cortices: a combined retrograde tracing in situ hybridization. J Comp Neurol 483: 351-373.
21. Kearn CS, Hilliard CJ (1997) Rat microglial cell express the peripheral-type cannabinoid receptor (CB2) which is negatively coupled to adenylyl cyclase. Proceedings of the Symposium on the Cannabinoids, Burlington, Vermont, International Cannabinoid Research Society, 57.
22. Kha HT, Finkelstein DJ, Pow DW, Lawrence AJ, Horne MK (2000) Study of projections from the entopeduncular nucleus to the thalamus of the rat. J Comp Neurol 426: 366-377.
23. Klein TW, Newton C., Larsen K., et al. (2003) The cannabinoid system and immune modulation. J Leukoc Biol 74: 486-496.
24. Liu Q. -R, Pan C. -H, Hishimoto A., et al. (2009) Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav 8: 519-530.
25. Malan Jr TP, Ibrahim MM, Vanderah TW, Makriyannis A., Porreca F. (2002) Inhibition of pain responses by activation of CB2 cannabinoid receptors. Chem Phys Lipids 121: 191-200.
26. Maldonado R., Valverde O., Berrendero F. (2006) Involvement of the endocannabinoid system in drug addiction. Trends Neurosci 29: 225-232.
27. Maresz K., Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN (2005) Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 95: 437-445.
28. Martin RF, Bowden DM (1997) Template Atlas of the Primate Brain. Seattle: University of Washington.
29. Núñez E., Benito C., Pazos MR, et al. (2004) Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse 53: 208-213.
30. Onaivi ES, Ishiguro H., Gong J-P., et al. (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann NY Acad Sci 1074: 514-536.
31. Parent A., Gravel S., Boucher R. (1981) The origin of forebrain afferents to the habenula in rat, cat and monkey. Brain Res Bull 6: 23-38.
32. Pertwee RG (1995) Cannabinoid Receptor Ligands. London: Academic Press.
33. Pertwee RG (1999) Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6: 635-664.
34. Schlicker E., Timm J., Zentner J., Göthert M. (1997) Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn Schmiedebergs Arch Pharmakol 356: 583-589.
35. Shen M., Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16: 4322-4334.
36. Skaper SD, Buriani A., Dal Toso R., et al. (1996) The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci U S A 30: 3984-3989.
37. Ständer S., Schmelz M., Metze D., Luger T., Rukwied R. (2005) Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory motor nerve fibers and adnexal structures in human skin. J Dermatol Sci 38: 177-188.
38. Stella N. (2004) Cannabinoid signaling in glial cells. Glia 48: 267-277.
39. Suárez J., Llorente R., Romero-Zerbo SY, et al. (2009) Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats. Hippocampus 19: 623-632.
40. Svízenska I., Dubovy P., Sulcová A. (2008) Cannabinoid receptors 1 and 2 (CB1 and CB2). their distribution, ligands and functional involvement in nervous system structures - a short review. Pharmacol Biochem Behav 90: 501-511.
41. Van Sickle MD, Duncan M., Kingsley PJ, et al. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310: 329-332.
42. Wotherspoon G., Fox A., McIntyre S., Colley S., Bevan S., Winter J. (2005) Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience 135: 235-245.